Glucocorticoids: action, indications and side effects

Glucocorticoids are a class of steroid hormones and drugs that act through glucocorticoid receptors, which are present in virtually all cells of the body. The primary endocrine hormone is cortisol, which is synthesized in the adrenal cortex and regulates metabolism, stress response, and immune system function. Synthetic and semi-synthetic glucocorticoids are used in medicine. They are significantly more potent than natural cortisol, allowing for the control of severe inflammation and autoimmune diseases, but also increasing the risk of serious side effects. [1]

Systemic glucocorticoids are prescribed for a wide range of conditions, including asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, systemic lupus erythematosus, vasculitis, inflammatory bowel disease, severe allergic reactions, cancer and hematological diseases, and organ transplantation. These drugs rapidly suppress inflammation and the immune response, which in many situations saves lives or prevents severe organ damage. However, a balance between benefit and risk is almost always required, as the systemic effects of glucocorticoids affect multiple organs and systems. [2]

In recent decades, new biological and targeted drugs have emerged, but glucocorticoids remain an important component of therapy for many diseases. Current guidelines emphasize the need to use the minimum effective dose and the shortest possible course, especially for rheumatic and autoimmune diseases. Long-term use, even at moderate doses, significantly increases the risk of osteoporosis, cardiovascular complications, diabetes, infections, and drug-induced adrenal insufficiency. [3]

Glucocorticoids are extremely effective in emergency situations, including anaphylactic shock, severe asthma, exacerbation of autoimmune diseases, exacerbation of inflammatory bowel disease, and acute adrenal crisis. In such situations, short-term high-dose therapy is justified, as the risk of discontinuing therapy far outweighs the risk of a short course. However, once the patient's condition has stabilized, the dose should be reduced and safer supportive treatments explored. [4]

At the same time, the widespread uncontrolled use of glucocorticoids, long-term courses without monitoring, and self-medication pose a major public health problem. Inappropriate use of these drugs leads to multiple complications, which may be irreversible. Therefore, patients should understand that glucocorticoids are not universal "anti-inflammatory pills," but rather powerful hormonal agents that require strict prescribing guidelines, appropriate dose reduction, and regular monitoring. [5]

Table 1. Brief characteristics of the class of glucocorticoids

Parameter	Description
Endogneous hormones	Cortisol, cortisone
The main target	Glucocorticoid receptor in the cell nucleus
Main action	Anti-inflammatory, immunosuppressant, metabolic
Main destinations	Oral, intravenous, intramuscular, inhalation, topical
Key risk	Complications of long-term therapy and the risk of adrenal insufficiency

Classification and examples of systemic drugs

Glucocorticoid medications include both natural hormones (hydrocortisone, cortisone) and numerous synthetic derivatives: prednisolone, methylprednisolone, triamcinolone, dexamethasone, betamethasone, and others. Synthetic medications were developed to enhance the anti-inflammatory effect, reduce mineralocorticoid activity, and offer different durations of action. This allows physicians to select a medication with the appropriate potency and duration of action for a specific clinical need. [6]

Glucocorticoids are typically classified by duration of action as short-acting, intermediate-acting, and long-acting. Short-acting glucocorticoids include hydrocortisone, intermediate-acting glucocorticoids include prednisolone and methylprednisolone, and long-acting glucocorticoids include dexamethasone and betamethasone. This distinction is important when planning a treatment regimen, selecting a drug for long-term therapy, and assessing the risk of adrenal insufficiency upon discontinuation. The longer the drug's action, the longer the suppression of cortisol secretion. [7]

Another important parameter is the relative glucocorticoid and mineralocorticoid activity. Hydrocortisone has a significant mineralocorticoid effect, meaning it retains sodium and water, increasing blood pressure. Prednisolone has a more pronounced anti-inflammatory effect with less fluid retention. Dexamethasone is a very potent anti-inflammatory drug with virtually no mineralocorticoid effect, making it suitable for situations where strong and prolonged suppression of the immune response is required but sodium retention is not stimulated. [8]

In clinical practice, the concept of hydrocortisone dose equivalent is often used to convert between drugs. For example, approximately 5 mg of prednisone or prednisolone corresponds to approximately 20 mg of hydrocortisone, and 0.75 mg of dexamethasone corresponds to the same 20 mg of hydrocortisone. These ratios are used when substituting one drug for another, when switching to physiological doses before discontinuing a drug, and when assessing the total hormonal load during long-term therapy. [9]

Combination forms also exist, where glucocorticoids are combined with other components, such as local anesthetics or antimicrobial agents for intra-articular or local injections. In systemic therapy, such combinations are used less frequently, with the primary focus being on pure glucocorticoid preparations with varying potency and duration of action, allowing for precise dosage adjustment and control of side effects. [10]

Table 2. Approximate relative potency of some systemic glucocorticoids

Preparation	Anti-inflammatory activity (relative to hydrocortisone)	Mineralocorticoid activity	Typical duration of action
Hydrocortisone	1	Expressed	Short
Prednisolone	About 4	Moderate	Average
Methylprednisolone	About 5	Low	Average
Dexamethasone	20-30	Almost absent	Long-term
Betamethasone	Similar to dexamethasone	Almost absent	Long-term

Mechanism of action and systemic effects

Glucocorticoids penetrate the cell membrane and bind to the intracellular glucocorticoid receptor. The hormone-receptor complex migrates to the cell nucleus, where it interacts with DNA regions and alters the activity of numerous genes responsible for the synthesis of proinflammatory and anti-inflammatory mediators, adhesion molecules, and metabolic enzymes. As a result, cytokine production is reduced, the migration of immune cells to the site of inflammation is inhibited, and tissue damage is reduced. [11]

At the immune system level, glucocorticoids suppress the activity of lymphocytes, macrophages, and other inflammatory cells. The production of interleukins, tumor necrosis factor, interferons, and other mediators is reduced. This leads to a reduction in pain, swelling, redness, and general inflammatory symptoms. However, the simultaneous suppression of the body's defenses makes the patient more vulnerable to bacterial, viral, and fungal infections, especially with long courses and high doses. [12]

Glucocorticoids significantly affect metabolism. They increase blood glucose levels by enhancing gluconeogenesis and reducing glucose utilization by tissues, alter fat distribution with the formation of a typical "steroid" phenotype, and promote protein loss in muscle and bone. These effects underlie the development of steroid-induced diabetes, sarcopenia, osteoporosis, and an increased risk of fractures with long-term use. [13]

Glucocorticoids affect the cardiovascular system both indirectly and directly. Through sodium and water retention (especially drugs with mineralocorticoid activity), circulating blood volume and blood pressure increase. Concurrently, vascular sensitivity to catecholamines increases. With long-term use, this contributes to the development of arterial hypertension, accelerated atherosclerosis, and an increased risk of cardiovascular events, especially in patients with underlying risk factors. [14]

Long-term use of glucocorticoids suppresses the hypothalamic-pituitary-adrenal axis. The body "adapts" to the external hormone and reduces endogenous cortisol production. Abrupt discontinuation or rapid dose reduction can lead to adrenal insufficiency, with severe weakness, a drop in blood pressure, and hypoglycemia. Current guidelines emphasize that the risk increases with doses equivalent to approximately 4-6 mg of prednisone or higher, for 3-4 weeks or more. [15]

Table 3. Main systemic effects of glucocorticoids

Body system	Main effects
Immune system	Suppression of cellular and humoral immunity, decreased production of cytokines
Musculoskeletal system	Bone loss, risk of osteoporosis and fractures, muscle weakness
Metabolism	Increased blood glucose, redistribution of adipose tissue, protein catabolism
Cardiovascular	Increased blood pressure, impact on cardiovascular risk
Endocrine system	Suppression of cortisol production, risk of adrenal insufficiency

Main indications for the use of systemic glucocorticoids

Systemic glucocorticoids are widely used in autoimmune and rheumatic diseases. In rheumatoid arthritis, vasculitis, polymyalgia rheumatica, systemic lupus erythematosus, and other systemic connective tissue diseases, they quickly reduce inflammation, relieve pain, and prevent organ damage. Current guidelines emphasize that glucocorticoids should be used in the lowest effective doses and for the shortest possible courses, along with basic medications that provide long-term control without elevated hormonal levels. [16]

In pulmonology, systemic glucocorticoids are indispensable for severe exacerbations of bronchial asthma, severe exacerbations of chronic obstructive pulmonary disease, certain interstitial lung diseases, and COVID-associated respiratory distress syndrome. However, for long-term maintenance therapy of bronchial asthma, preference is given to inhaled glucocorticoids, which provide local action with minimal systemic impact. [17]

In gastroenterology, systemic glucocorticoids are used for exacerbations of moderate to severe ulcerative colitis and Crohn's disease. They help quickly reduce mucosal inflammation, relieve pain, and normalize bowel movements. The goal of treatment is to transition to steroid-sparing therapy with immunosuppressants and biologics as soon as possible to reduce the risk of complications from long-term hormonal therapy. [18]

Emergency indications include anaphylaxis and severe allergic reactions, exacerbation of angioedema, severe drug hypersensitivity, and acute adrenal crisis. If adrenal crisis is suspected, systemic glucocorticoid administration is recommended immediately, without waiting for definitive confirmation of the diagnosis, as delay is life-threatening. Short-term administration of high doses in such situations is considered safe compared to the risk of failure to provide relief. [19]

Additional indications include hematological malignancies (e.g., lymphomas, leukemias), prevention and treatment of transplant rejection, certain neurological conditions (e.g., exacerbation of multiple sclerosis), severe dermatological diseases, and other rare pathologies. In all these cases, the decision to prescribe systemic glucocorticoids is made individually, taking into account alternatives and the projected duration of therapy. [20]

Table 4. Main groups of indications for systemic glucocorticoids

Field of medicine	Examples of diseases
Rheumatology	Rheumatoid arthritis, systemic lupus erythematosus, vasculitis
Pulmonology	Severe bronchial asthma, exacerbation of chronic obstructive pulmonary disease
Gastroenterology	Exacerbations of ulcerative colitis and Crohn's disease
Allergology	Anaphylaxis, severe drug and food reactions
Oncohematology and transplantology	Lymphomas, leukemia, organ rejection prevention

Release forms, administration regimens and dosage tactics

Systemic glucocorticoids are available as tablets, oral solutions, solutions for intravenous and intramuscular administration, and as preparations for intra-articular and paravertebral administration. The choice of dosage form depends on the clinical situation: intravenous administration is used for emergency care, oral administration is more often used for long-term therapy, and intra-articular injections are used for localized joint diseases. Oral forms are convenient for gradual dosage adjustments and long-term use under physician supervision. [21]

The principle of "minimum effective dose for the minimum necessary duration" is key when prescribing systemic glucocorticoids. In acute conditions, short courses of high doses are often used, followed by a rapid reduction to zero or a low maintenance dose. For chronic conditions, the dose is selected individually, taking into account the disease activity, comorbidities, and the risk of complications. Current recommendations recommend avoiding long courses, even at low doses, if possible, switching to steroid-sparing therapy. [22]

During long-term therapy, it is important to distinguish between supraphysiological and physiological doses. Supraphysiological doses significantly exceed natural daily cortisol production and more strongly suppress the hypothalamic-pituitary-adrenal axis. Endocrine guidelines indicate that even a dose of approximately 4-6 mg of prednisone per day, taken for more than 3-4 weeks, can increase the risk of adrenal insufficiency, especially in the presence of other risk factors. This means that virtually any long-term course requires a well-thought-out dose reduction strategy. [23]

Dose reduction regimens depend on the duration and amount of treatment. Typically, a more rapid rate is acceptable at higher doses when the risk of exacerbation of the underlying condition is greater than the risk of adrenal insufficiency, and the rate of reduction is slower as physiological doses are approached. It is important to distinguish the symptoms of glucocorticoid withdrawal syndrome from manifestations of true adrenal insufficiency and exacerbation of the underlying condition, so dose reduction is always carried out under medical supervision. [24]

In hospital settings, pulse therapy with high doses of intravenous methylprednisolone or other glucocorticoids over several days is sometimes used for severe conditions. Such courses allow for rapid control of the aggressive inflammatory process, but do not eliminate the need for subsequent gradual dose reduction and complication prevention. The decision to administer pulse therapy should always be accompanied by a risk assessment, particularly for infectious and cardiovascular risks. [25]

Table 5. Principles of safe administration of systemic glucocorticoids

Principle	The essence
Minimum effective dose	Use the lowest dose that controls symptoms
Minimum duration	Strive for the shortest courses possible
Transition to steroid-sparing therapy	Connect basic and targeted drugs to reduce the dose of hormones
Planning a dose reduction	Discuss the withdrawal strategy with the patient in advance
Monitoring for complications	Regularly monitor blood sugar, body weight, blood pressure, and bone density.

Side effects of short-term and long-term use

Even short courses of glucocorticoids can cause significant side effects. Short-term reactions include sleep disturbances, increased irritability, mood swings, increased blood pressure, elevated blood glucose levels, and fluid retention. Patients often report increased appetite and weight gain after just a few days of therapy. These effects are usually reversible upon discontinuation or dose reduction, but require attention, especially in individuals with pre-existing hypertension and carbohydrate metabolism disorders. [26]

Long-term use leads to the development of a characteristic set of changes known as steroid morphology: a moon face, fat deposits in the neck and torso, and thinning of the limbs due to muscle loss. Simultaneously, the risk of obesity, diabetes, dyslipidemia, and hypertension increases. Taken together, this increases the likelihood of cardiovascular complications, including myocardial infarction and stroke, especially in the presence of other risk factors. [27]

One of the most serious long-term complications is glucocorticoid-induced osteoporosis. Bone loss occurs within the first few months of therapy, and the risk of vertebral and hip fractures increases significantly with prolonged use, even at moderate doses. Recent reviews emphasize that glucocorticoid-induced osteoporosis is often underestimated and requires active prevention: optimal calcium and vitamin D intake, bone mineral density assessment, and the use of anti-osteoporotic medications in high-risk individuals. [28]

The immunosuppressant effect of glucocorticoids increases the risk of bacterial, viral, and fungal infections. The incidence of pneumonia, herpes zoster, candidiasis, and opportunistic infections increases with concomitant immunosuppression. Short-term courses can also increase infectious risks, especially in the elderly and patients with comorbidities, but long-term regimens and combination regimens with other immunosuppressants pose the greatest risk. [29]

Additional complications include glaucoma and cataracts, steroid myopathy, aseptic necrosis of the femoral head, skin changes (skin thinning, stretch marks, delayed wound healing), and mental disorders (ranging from mild euphoria to severe depression and psychosis). The variety of side effects requires systematic monitoring and regular risk discussions with the patient to jointly make decisions about the duration and tactics of treatment. [30]

Table 6. Main groups of side effects of systemic glucocorticoids

Complications group	Examples
Metabolic	Steroid diabetes, weight gain, dyslipidemia
Musculoskeletal	Osteoporosis, fractures, myopathy, aseptic necrosis
Cardiovascular	Arterial hypertension, accelerated atherosclerosis
Infectious	Increased risk of bacterial, viral and fungal infections
Ophthalmological and dermatological	Cataracts, glaucoma, thinning skin, stretch marks

Contraindications and restrictions

An absolute contraindication to the use of systemic glucocorticoids is a known severe allergic reaction to a specific drug. Other restrictions are relative and require a balance of risk and potential benefit. For example, in uncontrolled systemic infections, glucocorticoids may worsen the prognosis, but in certain severe infectious conditions (e.g., septic shock, severe pneumonia of certain etiologies), short-term use reduces mortality when the dose and duration are appropriately chosen. [31]

Severe uncontrolled mental disorders, especially psychosis and severe depression with suicidal ideation, pose a serious limitation, as glucocorticoids themselves can provoke or exacerbate mental symptoms. In such cases, prescribing requires close consultation with a psychiatrist and consideration of whether other methods can achieve the desired effect. If prescribing is necessary, the lowest possible doses and short courses under strict supervision are preferable. [32]

Patients with severe osteoporosis and a history of multiple fractures are also at high risk. Even low doses taken long-term can lead to further bone loss. This is not always an absolute contraindication, but it requires immediate initiation of preventive and therapeutic measures to protect bone tissue and consideration of alternative anti-inflammatory strategies. [33]

In patients with poorly controlled diabetes mellitus, severe hypertension, or severe heart failure, glucocorticoids can significantly worsen the underlying disease. However, in some cases, their use is unavoidable, for example, in cases of vasculitis or exacerbation of severe asthma. In such situations, more frequent visits to the doctor, active adjustment of hypoglycemic and antihypertensive therapy, and careful monitoring are necessary. [34]

Long-term use of glucocorticoids without attempting to reduce the dose and switch to steroid-sparing agents is considered unfavorable practice. Current guidelines emphasize that "chronic low dose" is far from harmless, especially if treatment lasts for years. Every patient receiving systemic glucocorticoids should regularly review their indications with their physician and discuss the possibility of reducing the dose or switching to alternative methods. [35]

Table 7. Situations in which glucocorticoids require special caution

Situation	Potential problem
Severe mental disorders	Increased psychotic and depressive symptoms
Severe osteoporosis	High risk of new fractures
Uncontrolled diabetes	A sharp deterioration in glycemia
Uncontrolled hypertension	High blood pressure and cardiovascular risk
Long-term therapy without revision	Accumulation of chronic complications

Drug interactions

Glucocorticoids interact with many medications due to their effects on liver enzymes, fluid and electrolyte balance, the immune system, and metabolism. Drugs that enhance liver enzyme activity, such as some anticonvulsants and antituberculosis drugs, can accelerate glucocorticoid metabolism and reduce their effectiveness, requiring dosage adjustments. Conversely, enzyme inhibitors can increase hormone concentrations and increase the risk of side effects. [36]

The combination of glucocorticoids and nonsteroidal anti-inflammatory drugs significantly increases the risk of gastrointestinal damage, including ulcers and bleeding. This combination requires careful evaluation of the indications and, as a rule, the prescription of gastroprotective agents. In patients with additional risk factors, such as advanced age and anticoagulant use, this risk is even higher and should be discussed in detail. [37]

Glucocorticoids can weaken the effect of some antihypertensive and antidiabetic medications because they themselves increase blood pressure and glucose levels. This means that when initiating or increasing the dose of hormonal treatment, a review of the hypertension and diabetes treatment regimen is often necessary. Regular monitoring of parameters and proactive modification of therapy can reduce the risk of decompensation. [38]

In combination immunosuppressive therapy, such as for rheumatic, hematologic, and transplant diseases, glucocorticoids enhance the overall immunosuppressive effect. At the same time, the risk of severe infections, including opportunistic ones, increases. Such regimens often require prophylaxis against certain infections, vaccinating the patient in advance, and closely monitoring for any signs of infection. [39]

Particular attention is paid to interactions with medications the patient is taking regularly and independently, including over-the-counter medications and herbal remedies. Unintentionally adding or discontinuing such medications while on glucocorticoid therapy can lead to unexpected effects. Therefore, it is important for patients to inform their physician about all medications, supplements, and herbal preparations they plan to take. [40]

Table 8. Important drug interactions of glucocorticoids

Combination	The main risk
Glucocorticoids and nonsteroidal anti-inflammatory drugs	Increased risk of ulcers and gastrointestinal bleeding
Glucocorticoids and antidiabetic drugs	Deterioration of glycemic control
Glucocorticoids and antihypertensive drugs	Less blood pressure control
Glucocorticoids and other immunosuppressants	High risk of infections
Glucocorticoids and liver enzyme inducers	Decreased effectiveness of hormonal therapy

Special patient groups and prevention of complications

In elderly patients, glucocorticoids cause complications more frequently and more severely than in younger patients. Older age is associated with a higher incidence of osteoporosis, cardiovascular disease, diabetes, and chronic infections, so even moderate doses of hormones can cause serious problems. In this group, it is especially important to initially assess fracture risk, cardiovascular health, and plan for the prevention of side effects. [41]

In children and adolescents, systemic glucocorticoids can impair growth and sexual development and increase the risk of osteopenia and infections. However, in severe diseases, such as systemic vasculitis or nephrotic syndrome, they remain vital. Therefore, in children, the shortest possible courses are used, steroid-sparing therapy is switched to when possible, and growth, weight, and bone mineral density are regularly assessed. [42]

In patients with risk factors for osteoporosis (old age, low body weight, female gender, history of fractures), early screening of bone mineral density and prophylactic measures are recommended when initiating long-term glucocorticoid therapy. Depending on the risk, the use of osteoporosis medications may be indicated early in treatment. Recent reviews emphasize that active fracture prevention significantly reduces the long-term harm from hormonal therapy. [43]

Patients at high risk for adrenal insufficiency require particular caution. During long-term glucocorticoid therapy, they should be taught how to manage stressful situations, infections, and surgeries; sometimes, a temporary dose increase or a switch to parenteral forms is required. New guidelines for glucocorticoid-induced adrenal insufficiency emphasize the importance of patient education and having an action plan in case of worsening of the condition. [44]

In pregnant and lactating women, systemic glucocorticoids should only be prescribed with a clear understanding that the benefit to the mother outweighs the potential risk to the fetus or child. Hydrocortisone and prednisolone are considered relatively safer because they are partially inactivated by the placenta, while longer-acting medications are prescribed only for strict indications. During breastfeeding, a physician will assess the dosage and the need for a temporary break or change in feeding time. [45]

Table 9. Preventive measures for different groups of patients

Patient group	Basic measures to prevent complications
Elderly	Fracture risk assessment, blood pressure and sugar control
Children and teenagers	Minimizing the duration of the course, monitoring growth and bone density
Patients at risk of osteoporosis	Early prevention of osteoporosis, control of mineral density
Patients at risk of adrenal insufficiency	Training, patient passport, stress action plan
Pregnant and lactating women	Selecting safer drugs and regimens

Long-term therapy, monitoring and discontinuation

During long-term therapy with systemic glucocorticoids, regular patient monitoring is essential. A minimum set of measures includes monitoring blood pressure, body weight, waist circumference, glucose and lipid levels, assessment of osteoporosis symptoms, mood changes, and sleep. Depending on the underlying risk, additional measures may include densitometry, ophthalmological examination, infection risk assessment, and adrenal function testing. [46]

Monitoring adrenal function is particularly important during long-term therapy and after dose reduction to the physiological range. Joint guidelines from endocrine societies describe approaches to assessing the hypothalamic-pituitary-adrenal axis, including morning cortisol measurements and dynamic testing. The goal is to promptly identify patients with persistent axis suppression who require continued replacement therapy and stress management training. [47]

A glucocorticoid withdrawal plan should be discussed with the patient in advance, especially if long-term treatment is anticipated. It is important to explain that abrupt discontinuation can be dangerous, even if the dose appears small. Dose reduction at the end of the course is usually gradual, taking into account the patient's well-being, disease activity, and, if necessary, laboratory parameters. At the same time, it is necessary to assess for recurrence of the underlying disease symptoms so that steroid-sparing therapy can be adjusted promptly. [48]

If severe weakness, dizziness, nausea, or a drop in blood pressure occur while reducing the dose, consult a doctor immediately. These symptoms may indicate adrenal insufficiency, an exacerbation of the underlying condition, or withdrawal syndrome. In some cases, a temporary dose increase, a slower reduction, and further evaluation are required. Increasing the dose without consultation is dangerous and should be avoided. [49]

A mandatory element of long-term glucocorticoid management is regular reassessment of the indications. At each visit, the physician and patient should consider whether the dose can be reduced, whether a different therapy can be used, whether lifestyle and concomitant treatment can be optimized to reduce hormonal load. This dynamic approach allows for the preservation of the benefits of glucocorticoids while minimizing their harm. [50]

Table 10. Elements of comprehensive monitoring during long-term glucocorticoid therapy

Direction of monitoring	What do they control?
Metabolic profile	Glucose, lipids, body weight, waist circumference
Bone health	Bone mineral density and fracture risk
Cardiovascular risk	Blood pressure, symptoms of coronary heart disease
Adrenal function	Morning cortisol, dynamic tests if necessary
Mental and general condition	Mood, sleep, quality of life, symptoms of the underlying disease

Frequently asked questions

Can short-term glucocorticoid use be avoided without serious risks?
Short-term glucocorticoid courses, when dosed correctly, are generally safer than long-term use, but they are not without side effects, especially in people with risk factors. Even a short course can increase blood pressure and glucose levels, cause insomnia, and mood swings. Therefore, glucocorticoids should be prescribed by a physician who can assess the benefits and risks, not the patient themselves. [51]

Is it true that "low doses" of glucocorticoids are safe for long-term use?
Current data show that even low doses of systemic glucocorticoids, when used long-term, increase the risk of osteoporosis, cardiovascular complications, infections, and adrenal insufficiency. Therefore, the concept of a "safe chronic dose" is conditional: any long-term treatment requires monitoring and attempts to reduce the dose or switch to other drugs, if possible. [52]

Should I always taper off slowly, even after a short course?
After very short courses, such as up to 5 days at high doses, most people can stop taking the medication without tapering, as the risk of adrenal suppression is minimal. However, if taking it for more than 2-3 weeks, it is advisable to taper off gradually, especially if higher-than-normal doses were used. The specific regimen should always be discussed with a doctor. [53]

How can you protect your bones during glucocorticoid therapy?
Prevention includes adequate calcium and vitamin D intake, regular physical activity, smoking cessation, and alcohol limitation. In cases of high risk, it can also include the use of specific osteoporosis medications. Assessing bone mineral density and calculating fracture risk can help determine when to begin such therapy. It is important to begin prevention as early as possible rather than waiting for fractures to occur. [54]

What should I do if I experience severe weakness and dizziness while reducing my dose?
These symptoms may indicate low cortisol levels, a worsening underlying condition, or a nonspecific withdrawal syndrome. In this situation, you should immediately consult a doctor who will assess your condition and determine whether a temporary dose increase or additional testing is needed. Returning to a higher dose without consultation may mask the problem and delay proper diagnosis. [55]